Inhibikase Therapeutics Free Cash Flow (FCF) History (IKT)
Inhibikase Therapeutics reported −$27.8M in free cash flow for fiscal 2025, a decrease of $8.7M from the previous fiscal year.
View full Inhibikase Therapeutics company overviewInhibikase Therapeutics free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$27.8M | −$8.7M | — | — |
| 2024 | 2024-12-31 | −$19.1M | −$1.0M | — | — |
| 2023 | 2023-12-31 | −$18.1M | −$504,923 | — | −6947.87% |
| 2022 | 2022-12-31 | −$17.6M | −$3.3M | — | −14253.37% |
| 2021 | 2021-12-31 | −$14.3M | — | — | −461.11% |
Inhibikase Therapeutics quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$12.4M | −$6.9M | — | — |
| Q1 2026 | 2026-03-31 | −$12.1M | −$7.9M | — | — |
| Q4 2025 | 2025-12-31 | −$7.5M | −$2.2M | — | — |
| Q3 2025 | 2025-09-30 | −$10.6M | −$5.7M | — | — |
| Q2 2025 | 2025-06-30 | −$5.6M | −$519,857 | — | — |
| Q1 2025 | 2025-03-31 | −$4.1M | −$249,911 | — | — |
| Q4 2024 | 2024-12-31 | −$5.3M | −$1.2M | — | — |
| Q3 2024 | 2024-09-30 | −$4.9M | $823,796 | — | — |
| Q2 2024 | 2024-06-30 | −$5.1M | −$3.0M | — | — |
| Q1 2024 | 2024-03-31 | −$3.9M | — | — | — |
| Q3 2023 | 2023-09-30 | −$4.1M | — | — | −5159.16% |
| Q3 2022 | 2022-09-30 | −$5.7M | — | — | −78245.73% |
| Q3 2021 | 2021-09-30 | −$2.0M | — | — | −615.14% |
Inhibikase Therapeutics free cash flow growth trends
Inhibikase Therapeutics's latest reported quarter, Q2 2026, generated −$12.4M in free cash flow, a decrease of $6.9M year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Inhibikase Therapeutics filings at SEC.gov ↗